GSK Divests Genericised Brands in Australia to Aspen Pharmacare
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 8 (Table of Contents)
Published: 31 Aug-2012
DOI: 10.3833/pdr.v2012.i8.1794 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
GlaxoSmithKline (GSK) has agreed to sell the majority of its portfolio of non-promoted, genericised drugs in Australia to South Africa's Aspen Pharmacare for approximately £172 M (US$270 M) in cash...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS